Stay updated on BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or revision in the context of medical and healthcare-related publications and documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:05.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the need for histologic or cytologic confirmation of advanced solid tumors and other specific health conditions. Previously, this section only indicated that no information was provided.
    Difference
    15%
    Check dated 2024-05-22T21:03:19.000Z thumbnail image
  7. Check
    38 days ago
    Change Detected
    Summary
    The value 'Go to the classic website Go to the classic website 5 2' on the webpage has been updated to 'type of intervention Site Map 6 0'. This change likely indicates a modification related to medical and healthcare-related publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T23:15:01.000Z thumbnail image

Stay in the know with updates to BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.